AAHP Shares FDA’s Commitment to Protecting Public Health

December 19, 2017 In response to the U.S. Food and Drug Administration’s (FDA) draft guidance on homeopathic drug products released on Monday, December 18, 2017, the American Association of Homeopathic Pharmacists offers the following statement: The American Association of Homeopathic Pharmacists (AAHP) shares the FDA’s commitment to protecting public health and applauds the Agency’s plan to takeContinue Reading

Arnica montana: A Clinical Snapshot

By Todd Hoover, MD December 11, 2017 Arnica montana has been used for centuries as a phytomedicine for its analgesic and anti-inflammatory properties. Commonly known as Wolf’s bane or Leopard’s bane, this herb is found in high mountain pastures throughout Europe. The herb is extremely toxic when ingested due to the presence of helenalin inContinue Reading

2017 Year in Review

2017 was a busy year for AAHP. With a new administration in the White House and key legislative issues heating up, the association had a full plate. But together with our members, we made great strides in protecting our industry and bettering our businesses. Together, we: Developed a label disclaimer statement responsive to FTC’s NovemberContinue Reading

Steps Toward Building Grassroots Support

December 6, 2017 Since the FDA hearing and the FTC workshop in 2015, the homeopathic industry has received more attention than usual from regulators. While AAHP continually meets with congressional leaders in Washington and works with both agencies, your association is also working to mobilize stakeholders. It’s important for legislators to hear a cry ofContinue Reading

Recall Preparedness

By Mark Land, AAHP president November 20, 2017 Risks associated with the therapeutic use of healthcare products are real. Manufacturers and the U.S. Food and Drug Administration (FDA) balance these risks all of the time when making marketing authorization decisions. These risks can be evaluable or unanticipated. Evaluable risks from the direct chemical, physical, orContinue Reading

Homeopathic Recalls: What Companies Should Do to Prepare

By Ryan Gooley, recall consultant, Stericycle November 15, 2017 Recalls impact thousands of companies every year, and they represent serious risk for the brands impacted. Homeopathic recalls, especially those involving products meant for children or the elderly, can cause widespread media coverage and consumer panic, potentially flooding call center phone lines and overwhelming internal resources.Continue Reading

Upcoming Webinar to Highlight Homeopathic Drug Stability

MILWAUKIE, Ore. (Nov. 14, 2017) – The American Association of Homeopathic Pharmacists (AAHP) will host a two-part webinar series on stability studies for homeopathic drug products. Slated for Dec. 4 and Dec. 11, 2017, both from 1:00 – 2:00 p.m. ET, the webinars will be led by Pejman Parhami, senior director of quality systems forContinue Reading

Annual Certification of Drug Product Listings

By Leonard Krause, FDA Connect November 1, 2017 It is that time of year again. Days are getting shorter and colder, and AAHP members who manufacture homeopathic and over-the-counter (OTC) products need to renew their drug manufacturing establishments with U.S. Food and Drug Administration (FDA). This year, however, add one more item to the mix.Continue Reading

New Drug Listing Requirement and Timetable Effective this Month

By Eric Foxman, AAHP Secretary October 1, 2017 The FDA recently introduced new requirements for the annual drug product reporting period and a new Structured Product Labeling (SPL) submission type. These requirements apply to every drug product marketed in the United States, including all homeopathic drug products, and will require action from just about everyContinue Reading

The Long-Term Vision for AAHP

By Eric Foxman, AAHP secretary October 1, 2017 During the course of the summer, AAHP president Mark Land lead the various association committees in an intense introspective series of meetings to identify strengths and challenges for our association. Meeting by telephone, email, and even in person, the result of this summer’s efforts was an 80-pageContinue Reading